BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19149642)

  • 1. Postprandial glucose - a potential therapeutic target to reduce cardiovascular mortality.
    Peter R; Okoseime OE; Rees A; Owens DR
    Curr Vasc Pharmacol; 2009 Jan; 7(1):68-74. PubMed ID: 19149642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.
    Bonora E
    Int J Clin Pract Suppl; 2002 Jul; (129):5-11. PubMed ID: 12166607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA(1c) in subjects with Type 2 diabetes.
    Peter R; Dunseath G; Luzio SD; Chudleigh R; Choudhury SR; Owens DR
    Diabet Med; 2009 Oct; 26(10):974-80. PubMed ID: 19900228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.
    Giugliano D; Ceriello A; Razzoli E; Esposito K
    Clin Drug Investig; 2008; 28(4):199-210. PubMed ID: 18345710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated?
    Charpentier G; Riveline JP; Dardari D; Varroud-Vial M
    Drugs; 2006; 66(3):273-86. PubMed ID: 16526817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial glucose regulation: new data and new implications.
    Leiter LA; Ceriello A; Davidson JA; Hanefeld M; Monnier L; Owens DR; Tajima N; Tuomilehto J;
    Clin Ther; 2005; 27 Suppl B():S42-56. PubMed ID: 16519037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial glycaemic excursions and cardiovascular risk.
    Pradeepa R; Mohan V
    J Indian Med Assoc; 2011 Dec; 109(12):912, 917-20. PubMed ID: 23469575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial and basal hyperglycaemia in type 2 diabetes: Contributions to overall glucose exposure and diabetic complications.
    Monnier L; Colette C
    Diabetes Metab; 2015 Dec; 41(6 Suppl 1):6S9-6S15. PubMed ID: 26774019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What does postprandial hyperglycaemia mean?
    Heine RJ; Balkau B; Ceriello A; Del Prato S; Horton ES; Taskinen MR
    Diabet Med; 2004 Mar; 21(3):208-13. PubMed ID: 15008828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring.
    Wang JS; Tu ST; Lee IT; Lin SD; Lin SY; Su SL; Lee WJ; Sheu WH
    Diabetes Metab Res Rev; 2011 Jan; 27(1):79-84. PubMed ID: 21218511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HbA₁(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study.
    Borg R; Kuenen JC; Carstensen B; Zheng H; Nathan DM; Heine RJ; Nerup J; Borch-Johnsen K; Witte DR;
    Diabetologia; 2011 Jan; 54(1):69-72. PubMed ID: 20886203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept.
    Monnier L; Colette C; Owens DR
    Diabetes Metab Res Rev; 2009 Jul; 25(5):393-402. PubMed ID: 19437415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of postprandial hyperglycemia in cardiovascular disease.
    Fava S
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):859-72. PubMed ID: 18570623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes.
    Yacoub T
    Postgrad Med; 2017 Nov; 129(8):791-800. PubMed ID: 29032696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of postprandial and fasting glucose concentrations on HbA1c in patients with type 2 diabetes.
    Schernthaner G; Guerci B; Gallwitz B; Rose L; Nicolay C; Kraus P; Kazda C
    Diabetes Metab; 2010 Nov; 36(5):389-94. PubMed ID: 20598608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting prandial hyperglycemia: how important is it and how best to do this?
    Monnier L; Colette C
    Curr Diab Rep; 2008 Oct; 8(5):368-74. PubMed ID: 18778585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial dysmetabolism and large-vessel disease.
    Segal P
    Diabetes Nutr Metab; 2002 Dec; 15(6 Suppl):3-8. PubMed ID: 12702001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of fasting and postprandial hyperglycemia to hemoglobin A1c in insulin-treated Japanese diabetic patients.
    Shimizu H; Uehara Y; Okada S; Mori M
    Endocr J; 2008 Aug; 55(4):753-6. PubMed ID: 18497454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of glycated haemoglobin (HbA(1c)) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes.
    Yu PC; Bosnyak Z; Ceriello A
    Diabetes Res Clin Pract; 2010 Jul; 89(1):1-9. PubMed ID: 20494468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.